DEVI MOON: Open Payments
NPI 1407469638 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$96 in 6 payments from 3 companies in 2025. Trend: 2023 $156 · 2024 $212 · 2025 $96
Food & beverage: $96
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Novo Nordisk Inc | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Qelbree, Ozempic, FARXIGA.
Industry payments across MS — which companies pay providers there.
